-
Je něco špatně v tomto záznamu ?
Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains
K Urbanek, M Kolar, Y Loveckova, J Strojil, L Santava
Jazyk angličtina Země Velká Británie
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1998-02-01
Medline Complete (EBSCOhost)
od 1998-02-01
Wiley Online Library (archiv)
od 1997-01-01 do 2012-12-31
- MeSH
- beta-laktamasy analýza metabolismus MeSH
- beta-laktamová rezistence MeSH
- cefalosporiny aplikace a dávkování terapeutické užití MeSH
- databáze faktografické MeSH
- financování organizované MeSH
- hodnocení spotřeby léčiv MeSH
- infekce bakteriemi rodu Klebsiella farmakoterapie mikrobiologie MeSH
- infekce spojené se zdravotní péčí mikrobiologie MeSH
- Klebsiella pneumoniae účinky léků MeSH
- lidé MeSH
- mikrobiální testy citlivosti MeSH
- nemocnice univerzitní MeSH
- retrospektivní studie MeSH
- Check Tag
- lidé MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc. METHODS: Data on the utilization of antibiotics in the hospital were obtained for the period 1997-2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients. RESULTS: Consumption of third-generation cephalosporins, which was 1.79 DBD in 1997, decreased to 0.93 in 1999, remained stable until 2002, and then increased to 2.40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%. CONCLUSIONS: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.
- 000
- 03299naa 2200445 a 4500
- 001
- bmc10012708
- 003
- CZ-PrNML
- 005
- 20121123112542.0
- 008
- 100526s2007 xxk e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Urbánek, Karel, $d 1969- $7 xx0078289
- 245 10
- $a Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains / $c K Urbanek, M Kolar, Y Loveckova, J Strojil, L Santava
- 314 __
- $a Department of Pharmacology, Faculty of Medicine and University Hospital, Olomouc, Czech Republic. urbanek@fnol.cz
- 520 9_
- $a BACKGROUND: Klebsiella pneumoniae belongs to important nosocomial pathogens causing mainly hospital-acquired infections. Beta-lactam antibiotics are frequently used in the treatment of infections caused by K. pneumoniae, but by their selection pressure the bacteria become resistant. Excessive use of third-generation cephalosporins is a risk factor for the occurrence and spread of ESBL-producing bacterial strains. The goal of this study was to describe the utilization of third-generation cephalosporins and to analyse their selection pressure on K. pneumoniae in the University Hospital in Olomouc. METHODS: Data on the utilization of antibiotics in the hospital were obtained for the period 1997-2005 from the computerized database and expressed in defined daily doses per 100 bed-days (DBD). The data were processed according to the ATC/DDD system. Klebsiella pneumoniae strains were isolated from clinical material obtained from hospitalized patients. RESULTS: Consumption of third-generation cephalosporins, which was 1.79 DBD in 1997, decreased to 0.93 in 1999, remained stable until 2002, and then increased to 2.40 DBD in 2005. During the 9-year period analysed, a total of 9564 strains of K. pneumoniae were isolated. The ESBL-positive K. pneumoniae strains frequency increased from 8% to 18%. CONCLUSIONS: Increasing utilization of third-generation cephalosporins was associated with a statistically and clinically significant increased incidence of ESBL-positive K. pneumoniae strains.
- 650 _2
- $a cefalosporiny $x aplikace a dávkování $x terapeutické užití $7 D002511
- 650 _2
- $a infekce spojené se zdravotní péčí $x mikrobiologie $7 D003428
- 650 _2
- $a databáze faktografické $7 D016208
- 650 _2
- $a hodnocení spotřeby léčiv $7 D017723
- 650 _2
- $a nemocnice univerzitní $7 D006785
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a infekce bakteriemi rodu Klebsiella $x farmakoterapie $x mikrobiologie $7 D007710
- 650 _2
- $a Klebsiella pneumoniae $x účinky léků $7 D007711
- 650 _2
- $a mikrobiální testy citlivosti $7 D008826
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a beta-laktamová rezistence $7 D018440
- 650 _2
- $a beta-laktamasy $x analýza $x metabolismus $7 D001618
- 650 _2
- $a financování organizované $7 D005381
- 651 _2
- $a Česká republika $7 D018153
- 700 1_
- $a Kolář, Milan, $d 1964- $7 jn20010310083
- 700 1_
- $a Lovečková, Yvona, $d 1965- $7 xx0073944
- 700 1_
- $a Strojil, Jan, $d 1978- $7 xx0107792
- 700 1_
- $a Šantavá, Lucie. $7 xx0211051
- 773 0_
- $t Journal of Clinical Pharmacy & Therapeutics $w MED00007277 $g Roč. 32, č. 4 Aug (2007), s. 403-408 $x 0269-4727
- 910 __
- $a ABA008 $b x $y 8
- 990 __
- $a 20100531112736 $b ABA008
- 991 __
- $a 20121123112605 $b ABA008
- 999 __
- $a ok $b bmc $g 726563 $s 589720
- BAS __
- $a 3
- BMC __
- $a 2007 $b 32 $c 4 Aug $d 403-408 $i 0269-4727 $m Journal of clinical pharmacy and therapeutics $n J Clin Pharm Ther $x MED00007277
- LZP __
- $a 2010-B2/vtme